Efficacy of fludarabine, mitoxantrone, dexamethasone alternating with cyclophosphamide, doxorubicin, vincristine and prednisone (FMD/CHOP) in bulky follicular non-Hodgkin's lymphoma

被引：0
|
作者：
Wilder, DD
Ogden, JL
Jain, VK
机构：
[1] Baylor Charles A Sammons Canc Ctr, Dallas, TX USA
[2] Texas Oncol PA, Dallas, TX USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2529
引用
收藏
页码：603A / 603A
页数：1
相关论文
共 50 条
  • [41] Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma
    Muringampurath-John, Disni
    Flowers, Christopher R.
    Toscano, Michael
    Chen Zhengjia
    Kaufman, Jonathan L.
    Arellano, Martha
    Bernal-Mizrachi, Leon
    Heffner, Leonard T.
    Lechowicz, Mary-Jo
    McLemore, Morgan
    Winton, Elliott
    Jaye, David L.
    Lonial, Sagar
    Khoury, Hanna Jean
    LEUKEMIA & LYMPHOMA, 2012, 53 (04) : 725 - 727
  • [42] Fludarabine-Mitoxantrone Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients
    Zinzani, Pier Luigi
    Pellegrini, Cinzia
    Broccoli, Alessandro
    Gandolfi, Letizia
    Stefoni, Vittorio
    Casadei, Beatrice
    Maglie, Roberto
    Argnani, Lisa
    Pileri, Stefano
    HEMATOLOGICAL ONCOLOGY, 2015, 33 (03) : 141 - 146
  • [43] MabThera (Rituximab) plus cyclophosphamide, vincristine and prednisone (CVP) chemotherapy improves survival in previously untreated patients with advanced follicular non-Hodgkin's lymphoma (NHL).
    Marcus, Robert E.
    Solal-Celigny, Philippe
    Imrie, Kevin
    Catalano, John V.
    Dmoszynska, Anna
    Raposo, Joao C.
    Offner, Fritz C.
    Gomez-Codina, Jose
    BLOOD, 2006, 108 (11) : 146A - 146A
  • [44] Obinutuzumab (GA101) in combination with CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) or bendamustine for the first-line treatment of follicular non-Hodgkin lymphoma: final results from the maintenance phase of the phase Ib GAUDI study
    Dyer, M. J. S.
    Grigg, A.
    Diaz, M. Gonzalez
    Dreyling, M.
    Rule, S.
    Lei, G.
    Wassner-Fritsch, E.
    Knapp, A.
    Marlton, P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 53 - 53
  • [45] Remission of follicular non-Hodgkin's lymphoma with denileukin diftitox (ONTAK®) after progression during rituximab, CHOP and fludarabine therapy
    Paschal, BR
    LEUKEMIA & LYMPHOMA, 2003, 44 (04) : 731 - 733
  • [46] Obinutuzumab (GA101) in Combination with CHOP (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) or Bendamustine for the First-Line Treatment of Follicular Non-Hodgkin Lymphoma: Final Results from the Maintenance Phase of the Phase Ib GAUDI Study
    Dyer, Martin J. S.
    Grigg, Andrew P.
    Gonzalez Diaz, Marcos
    Dreyling, Martin
    Rule, Simon
    Lei, Guiyuan
    Wassner-Fritsch, Elisabeth
    Fingerle-Rowson, Geunter
    Marlton, Paula V.
    BLOOD, 2014, 124 (21)
  • [47] Phase II study of cyclophosphamide, prednisone, and etoposide (CEOP-E) lymphoma epirubicin, vincristine, for aggressive non-Hodgkin's
    Kim, JG
    Sohn, SK
    Kim, DH
    Baek, JH
    Park, TI
    Lee, KB
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2004, 19 (06) : 820 - 825
  • [48] A phase II trial of pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone (DR-COP) in aggressive B-cell non-Hodgkin's lymphoma
    Tulpule, A
    Khan, AU
    Mohrbacher, AF
    Espina, BM
    Buchanan, L
    Berman, N
    Gorospe, G
    Boswell, WD
    Nathwani, BN
    Levine, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 604S - 604S
  • [49] Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma
    Visani, G
    Guiducci, B
    D'Adamo, F
    Mele, A
    Nicolini, G
    Leopardi, G
    Sparaventi, G
    Barulli, S
    Malerba, L
    Isidori, A
    Malagola, M
    Piccaluga, PP
    LEUKEMIA & LYMPHOMA, 2005, 46 (03) : 477 - 479
  • [50] A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma -: Cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy
    Mead, GM
    Bleehen, NM
    Gregor, A
    Bullimore, J
    Murrell, DS
    Rampling, RP
    Roberts, JT
    Glaser, MG
    Lantos, P
    Ironside, JW
    Moss, TH
    Brada, M
    Whaley, JB
    Stenning, SP
    CANCER, 2000, 89 (06) : 1359 - 1370
12345